Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
iShares US Technology ETF
IYW
$24B
| $2.44M | ﹤0.01% |
24,080
-511
| -2% | -$53.3K |
|
|
BRSP
2352
BrightSpire Capital
BRSP
$647M
| $2.44M | ﹤0.01% |
259,445
+144,643
| +126% | +$1.4M |
|
|
DADA
2353
DELISTED
Dada Nexus
DADA
| $2.43M | ﹤0.01% |
121,463
+20,178
| +20% | +$457K |
|
2354
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.35B
| $2.43M | ﹤0.01% |
18,710
-4,922
| -21% | -$649K |
|
2355
Hawaiian Electric Industries
HE
$2.2B
| $2.43M | ﹤0.01% |
59,563
+37,031
| +164% | +$1.59M |
|
|
WPCB.U
2356
DELISTED
Warburg Pincus Capital Corporation I-B Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
WPCB.U
| $2.43M | ﹤0.01% |
245,000
+145,000
| +145% | +$1.45M |
|
2357
Rocket Pharmaceuticals
RCKT
$364M
| $2.42M | ﹤0.01% |
81,129
-30,872
| -28% | -$1.12M |
|
2358
CONMED
CNMD
$1.56B
| $2.42M | ﹤0.01% |
18,509
-3,323
| -15% | -$435K |
|
2359
Walker & Dunlop
WD
$1.77B
| $2.42M | ﹤0.01% |
21,328
-6,536
| -23% | -$685K |
|
|
KREF
2360
KKR Real Estate Finance Trust
KREF
$458M
| $2.42M | ﹤0.01% |
114,601
+57,005
| +99% | +$1.21M |
|
2361
Sonos
SONO
$1.84B
| $2.42M | ﹤0.01% |
74,734
+27,452
| +58% | +$989K |
|
|
FLNA
2362
Filana Therapeutics
FLNA
$49.8M
| $2.42M | ﹤0.01% |
38,901
+29,391
| +309% | +$2.45M |
|
|
SWTX
2363
DELISTED
SpringWorks Therapeutics
SWTX
| $2.41M | ﹤0.01% |
38,026
-16,720
| -31% | -$1.29M |
|
2364
iShares Expanded Tech Sector ETF
IGM
$10.2B
| $2.41M | ﹤0.01% |
35,778
-648
| -2% | -$45K |
|
2365
Hilton Grand Vacations
HGV
$3.6B
| $2.41M | ﹤0.01% |
50,578
-7,218
| -12% | -$306K |
|
2366
PUT
State Street Communication Services Select Sector SPDR ETF
XLC
$22.4B
| $2.4M | ﹤0.01% |
30,000
| – | – |
|
|
CALY
2367
Callaway Golf Company
CALY
$3.38B
| $2.4M | ﹤0.01% |
86,920
+45,465
| +110% | +$1.38M |
|
2368
World Kinect Corp
WKC
$2.03B
| $2.4M | ﹤0.01% |
71,320
+7,392
| +12% | +$237K |
|
2369
Ingevity
NGVT
$2.53B
| $2.4M | ﹤0.01% |
33,561
+20,073
| +149% | +$1.58M |
|
|
DEA
2370
Easterly Government Properties
DEA
$1.16B
| $2.39M | ﹤0.01% |
46,350
-7,749
| -14% | -$419K |
|
2371
Immunovant
IMVT
$7.94B
| $2.39M | ﹤0.01% |
275,049
-44,829
| -14% | -$404K |
|
2372
Gentherm
THRM
$1.27B
| $2.38M | ﹤0.01% |
29,453
-5,867
| -17% | -$464K |
|
2373
CALL
Stryker
SYK
$128B
| $2.37M | ﹤0.01% |
9,000
| – | – |
|
2374
PUT
SLB Ltd
SLB
$73.3B
| $2.37M | ﹤0.01% |
+80,000
| New | +$2.29M |
|
2375
Mitsubishi UFJ Financial
MUFG
$254B
| $2.36M | ﹤0.01% |
398,641
-187,481
| -32% | -$1.04M |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.